Insmed (INSM) Other Operating Expenses (2011 - 2026)
Insmed's (INSM) quarterly Other Operating Expenses came in at $2.5 million in Q1 2026, down 93.78% year-on-year from $40.8 million in Q1 2025, and down 97.81% quarter-over-quarter from $116.2 million in Q4 2025.
Insmed (INSM) Other Operating Expenses (2011 - 2026) Analysis & Trends
Insmed's Other Operating Expenses history runs 12 years deep, the most recent figure standing at $2.5 million for Q1 2026.
- On a quarterly basis, Other Operating Expenses fell 93.78% year-over-year to $2.5 million in Q1 2026; TTM through Mar 2026 was $342.6 million, a 58.26% increase from a year earlier, with the FY2025 full-year figure at $380.9 million, up 108.76% from the prior year.
- Other Operating Expenses declined to $2.5 million in Q1 2026 per INSM's latest filing, from $116.2 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $135.6 million in Q3 2025 and bottomed at $1.8 million in Q1 2022.
- The 5-year median for Other Operating Expenses is $27.0 million (2023), against an average of $41.4 million.
- Across the five-year window, Other Operating Expenses jumped 821.17% in 2025 and sank 93.78% in 2026, its largest moves.
- Year by year, Other Operating Expenses stood at $12.5 million in 2022, then jumped by 182.5% to $35.4 million in 2023, then slumped by 64.37% to $12.6 million in 2024, then soared by 821.17% to $116.2 million in 2025, then plunged by 97.81% to $2.5 million in 2026.
- Per Business Quant, the three latest INSM Other Operating Expenses figures stand at $2.5 million (Q1 2026), $116.2 million (Q4 2025), and $135.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Insmed | 23.26 Bn | 22.03 Bn | 258.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.54 Mn |
| Dec 31, 2025 | 116.20 Mn |
| Sep 30, 2025 | 135.56 Mn |
| Jun 30, 2025 | 88.34 Mn |
| Mar 31, 2025 | 40.84 Mn |
| Dec 31, 2024 | 12.61 Mn |
| Sep 30, 2024 | 37.12 Mn |
| Jun 30, 2024 | 125.93 Mn |
| Mar 31, 2024 | 6.82 Mn |
| Dec 31, 2023 | 35.41 Mn |
| Sep 30, 2023 | 26.97 Mn |
| Jun 30, 2023 | 31.36 Mn |
| Mar 31, 2023 | 5.59 Mn |
| Dec 31, 2022 | 12.53 Mn |
| Sep 30, 2022 | 19.97 Mn |
| Jun 30, 2022 | 5.04 Mn |
| Mar 31, 2022 | 1.84 Mn |
| Dec 31, 2021 | 13.58 Mn |
| Sep 30, 2021 | 19.75 Mn |
| Jun 30, 2021 | 12.10 Mn |